Latest debt-to-equity ratio
X4 Pharmaceuticals Debt-to-equity ratio
Direct answer
X4 Pharmaceuticals's debt-to-equity ratio is 49.68%.
The verified market snapshot reports 49.68%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 12, 2026.
Get free X4 Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 49.68%
Explore related company data
View X4 Pharmaceuticals's market capitalizationView X4 Pharmaceuticals's p/e ratioView X4 Pharmaceuticals's price-to-book ratioView X4 Pharmaceuticals's return on equityView X4 Pharmaceuticals's dividend yieldView X4 Pharmaceuticals's 52-week price rangeView X4 Pharmaceuticals's revenue growthView X4 Pharmaceuticals's profit marginView all X4 Pharmaceuticals key metricsReturn to X4 Pharmaceuticals profile